CDER News

Consumer Directed Questions and Answers about FDA’s Initiative Against Contaminated Weight Loss Products (updated)

Drugs@FDA Downloadable Data Files (updated)

The U.S. Food and Drug Administration today announced that a facility owned by India-based Ranbaxy Laboratories falsified data and test results in approved and pending drug applications. The facility, Paonta Sahib, has been under an FDA Import Alert since September 2008.

Approved Drug Products with Therapeutic Equivalence Evaluations Orange Book (updated)

FDA Center for Drug Evaluation and Research News